AUTHOR=Sang-Ngoen Thanyaporn , Czumbel László Márk , Sadaeng Wuttapon , Mikó Alexandra , Németh Dávid István , Mátrai Péter , Hegyi Péter , Tóth Barbara , Csupor Dezső , Kiss István , Szabó Andrea , Gerber Gábor , Varga Gábor , Kerémi Beáta 

TITLE=Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis

JOURNAL=Frontiers in Pharmacology

VOLUME=12

YEAR=2021

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.682656

DOI=10.3389/fphar.2021.682656

ISSN=1663-9812

ABSTRACT=<p><bold>Introduction:</bold> At the initial part of the gastrointestinal tract, multiple tissues serve the normal function of food delivery. Periodontal structures are integral elements of these. When they deteriorate, it is extremely challenging to regenerate and reconstruct them. The conventional intervention for periodontal disease is scaling and root planning with the aim of reducing pathogenic bacteria. However, periodontal pathogens can rapidly recolonize treated areas. Probiotics have been proposed as novel tools for managing oral health by suppressing pathogenic bacteria through their anti-inflammatory effect, but the available data are controversial.</p><p><bold>Aim:</bold> Therefore, we performed a meta-analysis to study the effect of probiotics on periodontal pathogenic bacteria.</p><p><bold>Methods:</bold> The study was registered in PROSPERO under registration number CRD42018094903. A comprehensive literature search from four electronic databases (PubMed, Cochrane CENTRAL, Embase, and Web of Science) yielded nine eligible records for statistical analysis. Studies measuring bacterial counts in saliva and supra- and subgingival plaque were included. Bacterial counts were analyzed using standard mean difference (SMD) and by a random effects model with the DerSimonian–Laird estimation.</p><p><bold>Results:</bold> The results showed a significant decrease in the overall count of <italic>Aggregatibacter actinomycetemcomitans</italic> in the probiotic-treated group compared to the control at 4 weeks (SMD: −0.28; 95% CI: −0.56–−0.01; <italic>p</italic> = 0.045) but not later. Analyzing the bacterial counts in subgroups, namely, in saliva and supra- and subgingival plaque, separately, yielded no significant difference. Probiotics had no significant effect on the overall count of <italic>Porphyromonas gingivalis</italic> at 4 weeks (SMD: −0.02; 95% CI: −0.35−0.31; <italic>p</italic> = 0.914) or later. Subgroup analysis also revealed no significant difference between treatment and control groups nor did probiotics significantly decrease the overall and subgroup bacterial counts of <italic>Prevotella intermedia</italic>, <italic>Tannerella forsythia</italic>, and <italic>Fusobacterium nucleatum</italic>.</p><p><bold>Conclusion:</bold> Our data support the beneficial effect of probiotics in reducing <italic>A. actinomycetemcomitans</italic> counts, but not of other key periodontal pathogenic bacteria in periodontal disease patients. However, due to the complex mechanism associated with periodontal disease and the limitations of the available studies, there is a further need for well-designed randomized clinical trials to assess the efficacy of probiotics.</p>